Contact information
Type
Scientific
Primary contact
Prof Graham Foster
ORCID ID
Contact details
Institute of Cell and Molecular Science
Medical College
Turner Street
London
E1 2AD
United Kingdom
+44 20 7882 2483
g.r.foster@qmul.ac.uk
Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
11278
Study information
Scientific title
Discharge planning for the homeless, examining The London Pathway. Does a GP led discharge team reduce the inpatient burden and improve quality of care?
Acronym
Study hypothesis
The London Pathway model of care for people who are homeless improves the quality of care and reduces overall length of hospital stay.
http://public.ukcrn.org.uk/search/StudyDetail.aspx?StudyID=11278
Ethics approval
London South East ethics committee, ref:11/LO/0755
Study design
Interventional randomised open label controlled clinical trial; Design type: Process of Care, Treatment
Primary study design
Interventional
Secondary study design
Randomised controlled trial
Trial setting
Not specified
Trial type
Quality of life
Patient information sheet
Condition
Topic: Primary Care Research Network for England, Oral and Gastrointestinal, Generic Health Relevance and Cross Cutting Themes; Subtopic: Oral and Gastrointestinal (all Subtopics), Generic Health Relevance (all Subtopics); Disease: All Diseases, Hepatology, Health Services Research
Intervention
Randomised trial of enhanced vs normal care for people who are homeless.
GP assisted care, GP to assist in management
Follow Up Length: 6 months
Intervention type
Other
Phase
Not Applicable
Drug names
Primary outcome measures
Length of stay; Timepoint: Duration of in-patient stay
Secondary outcome measures
Not provided at time of registration
Overall trial start date
01/12/2011
Overall trial end date
30/06/2013
Reason abandoned
Eligibility
Participant inclusion criteria
1. People admitted to one of the hospitals involved in the study who do not have a home of their own where they usually sleep at night
2. Male & Female, Lower Age Limit 18 years, Upper Age Limit 100 years
Participant type
Patient
Age group
Adult
Gender
Both
Target number of participants
UK Sample Size: 800; Description: Based on projected 20% reduction in length of stay
Participant exclusion criteria
1. Unwilling or unable to provide informed consent
2. Temporarily homeless (defined as likely to be without accommodation for less than 2 weeks)
Recruitment start date
01/12/2011
Recruitment end date
30/06/2013
Locations
Countries of recruitment
United Kingdom
Trial participating centre
Institute of Cell and Molecular Science
London
E1 2AD
United Kingdom
Sponsor information
Organisation
Queen Mary, University of London (UK)
Sponsor details
School of Medicine and Dentistry
Clinical Sciences Research Centre
Rutland Place
Charterhouse Square
London
EC1M 6BQ
United Kingdom
Sponsor type
University/education
Website
Funders
Funder type
Government
Funder name
NIHR (UK) - Research for Patient Benefit (RfPB) RfPB PB-PG-0110-21014
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Results and Publications
Publication and dissemination plan
Not provided at time of registration
Intention to publish date
Participant level data
Not provided at time of registration
Results - basic reporting
Publication summary
2016 results in http://www.ncbi.nlm.nih.gov/pubmed/27251910